GlaxoSmithKline (GSK) Gains on Speculation Pfizer (PFE) is Eyeing the Company
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) is higher Monday (+2.4%) on chatter from overseas that after its unsuccessful hostile bid for AstraZeneca (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
